Novo Nordisk
NVO
#20
Rank
A$734.69 B
Marketcap
$161.74
Share price
2.15%
Change (1 day)
2.27%
Change (1 year)

Novo Nordisk A / S produces and markets pharmaceutical products and services. Since its founding in Denmark in 1923, the company has developed into a leading company in the diabetes sector worldwide.

Novo Nordisk (NVO) - Cash on Hand

Cash on Hand as of June 2024 : A$13.55 Billion

According to Novo Nordisk's latest financial reports the company has A$13.55 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Novo Nordisk - Cash on Hand chart (from 1996 to 2024)

Cash on Hand by year

Year Cash on Hand Change
2023-12-31A$6.57 B31.73%
2022-12-31A$4.98 B35.86%
2021-12-31A$3.67 B33.89%
2020-12-31A$2.74 B-17.25%
2019-12-31A$3.31 B-2.56%
2018-12-31A$3.40 B-12.63%
2017-12-31A$3.89 B-4.25%
2016-12-31A$4.06 B-1.24%
2015-12-31A$4.11 B29.7%
2014-12-31A$3.17 B5.69%
2013-12-31A$3.00 B9.29%
2012-12-31A$2.74 B-7.59%
2011-12-31A$2.97 B5.45%
2010-12-31A$2.82 B2.53%
2009-12-31A$2.75 B1.46%
2008-12-31A$2.71 B63.99%
2007-12-31A$1.65 B44.03%
2006-12-31A$1.14 B5.7%
2005-12-31A$1.08 B15.7%
2004-12-31A$0.93 B33.13%
2003-12-31A$0.70 B56.31%
2002-12-31A$0.45 B-48.28%
2001-12-31A$0.87 B161.93%
2000-12-31A$0.33 B17.88%
1999-12-31A$0.28 B48.83%
1998-12-31A$0.18 B-24.56%
1997-12-31A$0.25 B49.84%
1996-12-31A$0.16 B

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
A$10.67 B-21.27%๐Ÿ‡บ๐Ÿ‡ธ USA
A$5.28 B-60.99%๐Ÿ‡บ๐Ÿ‡ธ USA
A$12.16 B-10.26%๐Ÿ‡บ๐Ÿ‡ธ USA
A$10.94 B-19.24%๐Ÿ‡ซ๐Ÿ‡ท France